Article info

PDF

Extended report
Sirukumab for rheumatoid arthritis: the phase III SIRROUND-D study

Authors

  1. Correspondence to Dr Paul P Tak, GlaxoSmithKline Research and Development, Stevenage SG1 2NY, UK; Paul-peter.x.tak{at}gsk.com
View Full Text

Citation

Takeuchi T, Thorne C, Karpouzas G, et al
Sirukumab for rheumatoid arthritis: the phase III SIRROUND-D study

Publication history

  • Received 17 February 2017
  • Revised 11 July 2017
  • Accepted 18 July 2017
  • Published online 30 August 2017.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.